Adverse events ( AEs ) > 5 % were diarrhea , nausea , vomiting , and abdominal pain ( lubiprostone : 11.3 , 9.9 , 4.2 , and 7.1 % , respectively ; placebo , 3.8 , 4.7 , 5.2 , and 0 % , respectively ) .